BioCentury | Sep 14, 2015
Clinical News

VPM1002: Phase II started

...and -unexposed newborn infants. In 2013, the institute licensed rights to the vaccine from Vakzine. Vakzine Projekt Management GmbH...
BioCentury | Mar 31, 2014
Company News

CAP-CMV management update

...CAP-CMV GmbH , Cologne, Germany Business: Infectious Hired: Albrecht Laeufer as CEO, formerly CEO of Vakzine Projekt Management GmbH...
BioCentury | Jan 7, 2013
Company News

Cevec, Vakzine Project deal

...months. The partners could not be reached for details. Cevec Pharmaceuticals GmbH , Cologne, Germany Vakzine Projekt Management GmbH...
BioCentury | Mar 5, 2009
Targets & Mechanisms

Subunit boost for TB vaccines

...longer survival times. According to Leander Grode, director of business development and project manager at Vakzine Projekt Management GmbH...
...NYSE:SNY), Paris, France State Serum Institute , Copenhagen, Denmark University of Oxford , Oxford, U.K. Vakzine Projekt Management GmbH...
...NYSE:SNY)/Aeras/State Serum Institute VPM1002 Prime Recombinant urease C-deficient listeriolysin expressing bacille Calmette-Guérin vaccine Phase I Vakzine Projekt Management GmbH/Max...
BioCentury | Apr 10, 2006
Clinical News

VPM4001: Phase I/II data

...control (p<0.0035). PSA levels were stabilized for up to 639 days and treatment was safe. Vakzine Projekt Management GmbH...
BioCentury | Dec 12, 2005
Company News

Crucell, Vakzine Project deal

...a research license fee and annual maintenance fees. Crucell N.V. (Euronext:CRXL; CRXL), Leiden, the Netherlands Vakzine Projekt Management GmbH...
Items per page:
1 - 6 of 6
BioCentury | Sep 14, 2015
Clinical News

VPM1002: Phase II started

...and -unexposed newborn infants. In 2013, the institute licensed rights to the vaccine from Vakzine. Vakzine Projekt Management GmbH...
BioCentury | Mar 31, 2014
Company News

CAP-CMV management update

...CAP-CMV GmbH , Cologne, Germany Business: Infectious Hired: Albrecht Laeufer as CEO, formerly CEO of Vakzine Projekt Management GmbH...
BioCentury | Jan 7, 2013
Company News

Cevec, Vakzine Project deal

...months. The partners could not be reached for details. Cevec Pharmaceuticals GmbH , Cologne, Germany Vakzine Projekt Management GmbH...
BioCentury | Mar 5, 2009
Targets & Mechanisms

Subunit boost for TB vaccines

...longer survival times. According to Leander Grode, director of business development and project manager at Vakzine Projekt Management GmbH...
...NYSE:SNY), Paris, France State Serum Institute , Copenhagen, Denmark University of Oxford , Oxford, U.K. Vakzine Projekt Management GmbH...
...NYSE:SNY)/Aeras/State Serum Institute VPM1002 Prime Recombinant urease C-deficient listeriolysin expressing bacille Calmette-Guérin vaccine Phase I Vakzine Projekt Management GmbH/Max...
BioCentury | Apr 10, 2006
Clinical News

VPM4001: Phase I/II data

...control (p<0.0035). PSA levels were stabilized for up to 639 days and treatment was safe. Vakzine Projekt Management GmbH...
BioCentury | Dec 12, 2005
Company News

Crucell, Vakzine Project deal

...a research license fee and annual maintenance fees. Crucell N.V. (Euronext:CRXL; CRXL), Leiden, the Netherlands Vakzine Projekt Management GmbH...
Items per page:
1 - 6 of 6